Transplantation across previously incompatible immunological barriers.
about
Infectious complications in living-donor kidney transplant recipients undergoing multi-modal desensitization.Promising recent data on ABO incompatible liver transplantation: restrictions may apply.Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.Baseline Anti-blood Group Antibody Titers and their Response to Desensitization and Kidney Transplantation.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.A case of desensitization, transplantation, and allograft dysfunction.Current progress in ABO-incompatible kidney transplantationPediatric renal transplantation in a highly sensitised child-8 years on.Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allograftsAllorecognition and the alloresponse: clinical implications.Recent developments in kidney transplantation--a critical assessment.Segmental live donor pancreas transplantation: review and critique of rationale, outcomes, and current recommendations.Highly successful and low-cost desensitization regime for sensitized living donor renal transplant recipients.Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system.A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.Association of lymphocyte crossmatch and the outcome of intestinal transplantation in swine.Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs.
P2860
Q30361620-69722CAB-6DA3-472E-855E-DFE4EEAC1FACQ31117692-2779D245-A7C1-45E8-9485-2E049AE86AA9Q33165774-1D2344EF-7336-4B62-ADEC-FE68BD82EC89Q33697381-8850711E-D8E1-4D0B-B502-DE6D213BD4F2Q34122035-6923B02F-83A2-4BD9-8A8E-E92F324333F9Q35607565-83301D21-6AA0-45EE-A1AB-3376114F7647Q35715908-57BBCA35-9321-4E56-9290-A7063B9BDA88Q36063312-CB9CDC3E-CFA2-454E-B4B3-6AFB442D0977Q36171175-BCAC83E1-CF51-4934-9D93-88EA421DE30CQ36422175-15F85237-CAD8-401C-A244-C42A56F24FE1Q36778867-525A6CAE-29E0-476F-8341-B5ACA0B6B51CQ36820105-82330AD7-6C2A-4793-B496-BA616562291CQ37301840-E2F05270-9C60-44F1-82E3-B0225E6EECFDQ37821062-0C53328B-73C2-4851-B99B-0523D72579CDQ43258998-5FC6B441-AECA-4B20-908A-EB833E1B5AF6Q46857776-5CF52B2D-52BA-42E9-95B4-7CEFBF14BA5CQ47752841-57527B4B-95E7-4FE5-827E-98C5FD1E5D1AQ48290798-D2464132-3983-49D0-BC8D-EA6EB7E97D7CQ51895960-62101815-FD1F-4108-A880-0420CB3C2ED9Q51899612-3D7A97AB-CACE-4A76-A5A7-5C9A530EE76D
P2860
Transplantation across previously incompatible immunological barriers.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Transplantation across previously incompatible immunological barriers.
@ast
Transplantation across previously incompatible immunological barriers.
@en
type
label
Transplantation across previously incompatible immunological barriers.
@ast
Transplantation across previously incompatible immunological barriers.
@en
prefLabel
Transplantation across previously incompatible immunological barriers.
@ast
Transplantation across previously incompatible immunological barriers.
@en
P2860
P1476
Transplantation across previously incompatible immunological barriers.
@en
P2093
Colm C Magee
P2860
P356
10.1111/J.1432-2277.2005.00257.X
P577
2006-02-01T00:00:00Z